Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations

UnknownOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

June 12, 2020

Primary Completion Date

June 11, 2023

Study Completion Date

November 11, 2023

Conditions

COVIDDrug EffectDrug InteractionAdverse Drug Event

Trial Locations (1)

Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, Orlando